Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

97.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.9K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

601
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
601
Genomics02:02

Genomics

39.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-tissue molecular responses in the liver and blood after toxicant exposures.

Research square·2025
Same author

Toxicogenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource.

Research square·2025
Same author

Comprehensive Transcriptomic and Epigenomic Insights into Environmental Toxicant Exposures: The TaRGET II Resource.

bioRxiv : the preprint server for biology·2025
Same author

Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review.

Journal of medical economics·2025
Same author

Can Pharmacogenetics Be Used to Predict the Response to Fesoterodine Fumarate?

Urogynecology (Philadelphia, Pa.)·2025
Same author

Medical policy determinations for pharmacogenetic tests among US health plans.

The American journal of managed care·2025

Related Experiment Video

Updated: Jan 19, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.

Oscar Suzuki1,2, Olivia M Dong1,2, Rachel M Howard1,2

  • 1Division of Pharmacotherapy & Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Pharmacogenomics
|September 28, 2019
PubMed
Summary

A new targeted next-generation sequencing (NGS) test efficiently analyzes 21 pharmacogenetic (PGx) genes. This cost-effective genetic test offers high accuracy for pharmacogenomic profiling.

Keywords:
molecular inversion probesnext-generation sequencingpharmacogeneticpharmacogenomeprecision medicine

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.6K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K

Related Experiment Videos

Last Updated: Jan 19, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.6K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K

Area of Science:

  • Pharmacogenomics
  • Molecular Diagnostics
  • Genetics

Background:

  • Pharmacogenetic (PGx) testing aids in personalized medicine by predicting drug response.
  • Developing efficient and cost-effective PGx assays is crucial for clinical implementation.

Purpose of the Study:

  • To evaluate the technical performance and cost-effectiveness of a targeted next-generation sequencing (NGS) multigene PGx test.
  • To assess the accuracy and reliability of a novel PGx assay for clinical use.

Main Methods:

  • Developed a targeted NGS assay for 21 PGx genes using molecular inversion probes.
  • Validated the assay's performance using 53 reference control cell lines from the Genetic Testing Reference Materials Coordination Program (GeT-RM).

Main Results:

  • Achieved 93.7% variant call rate and 99.9% repeatability.
  • Obtained 85.7% concordance with reference calls for diplotype analysis.
  • Determined a cost per sample ranging from $32 to $56.

Conclusions:

  • A targeted NGS assay employing molecular inversion probe technology provides efficient pharmacogenomic characterization.
  • The developed assay demonstrates strong technical performance and cost-effectiveness for PGx testing.